If you want to be aware of the latest scientific findings in the medical benefits of cannabis, MJWellness has collected the top 10 marijuana-related studies released in 2016 that exemplify the healing properties of the herb.
A study released in the journal Health Economics has discovered a positive interaction between medical cannabis legalization and full-time employee's absences. According to the study findings, the legalization of the herb in American states has resulted in the decrease of the total number of workers' absences that were caused by sickness.
Nature Partner Journals has made available a study investigating the effect of cannabinoids on the brain inflammation caused by intracellular amyloid that increases with age. This type of inflammation can be dangerous for people as it damages brain neurons. The study results discovered that tetrahydrocannabinol (THC) enhanced toxic plaque removal and also reduced inflammation in the brain.
The U.S. National Institute of Health has recently published a study showing that cannabinoids can inhibit the growth of carcinoma cancer cells. Moreover, active cannabis compounds can potentially program active cancer cells for self-destruction.
A pilot investigation unveiled that marijuana benefited patients with bipolar disorder, as the journal PLoS ONE stated in June. According to this study, marijuana can help patients relieve their symptoms of bipolar disorder without any negative influence on their mood and cognitive function.
The journal Molecular Medicine Reports has recently published a study investigating the impact of medical marijuana on patients suffering from osteoarthritis. The study results have shown that cannabinoids may effectively prevent cartilage breakdown that often happens as a result of osteoarthritis.
This year's study released in the journal Cerebrovascular Diseases discovered that people who used cannabis prior to being hospitalized with intracerebral hemorrhaging (bleeding in the brain) had better outcomes and smaller brain injury comparing to cannabinoid-negative patients.
The journal Psychopharmacology has recently published a marijuana-related study that investigated the influence of cannabis and alcohol on the user's mood. During this random controlled trial, the researchers found that alcohol significantly increased aggression while marijuana significantly diminished aggressive feelings.
In February, the journal Seizure released clinical data, according to which children suffering from intractable epilepsy experienced fewer seizures after being treated with cannabis oil extracts high in cannabidiol (CBD). Scientists consider the study results “highly promising” and suggest that further investigations are warranted.
Marijuana use by school students is not associated with lower IQ and poorer educational performance in contrast to alcohol drinking or cigarette smoking, as was discovered in a study released by the Journal of Psychopharmacology. Modest cannabis use in adolescents may have a smaller cognitive impact on the teenagers' IQ than previous studies have suggested.
This year, a study published in the Journal of the American College of Cardiology found surprising results that marijuana consumers diagnosed with acute myocardial infarction experienced less negative outcomes during hospitalization compared to patients who did not consume marijuana before.